SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-006072
Filing Date
2018-12-19
Accepted
2018-12-19 16:38:53
Documents
62
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mblc_10q.htm 10-Q 244937
2 CERTIFICATION mblc_ex311.htm EX-31.1 8307
3 CERTIFICATION mblc_ex312.htm EX-31.2 8088
4 CERTIFICATION mblc_ex321.htm EX-32.1 2977
5 CERTIFICATION mblc_ex322.htm EX-32.2 2919
  Complete submission text file 0001477932-18-006072.txt   2320193

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thct-20181031.xml EX-101.INS 377602
7 XBRL TAXONOMY EXTENSION SCHEMA thct-20181031.xsd EX-101.SCH 38398
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20181031_cal.xml EX-101.CAL 41376
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20181031_def.xml EX-101.DEF 129094
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20181031_lab.xml EX-101.LAB 188555
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20181031_pre.xml EX-101.PRE 186976
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 702-602-8422
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55994 | Film No.: 181243833
SIC: 3523 Farm Machinery & Equipment